Jim Chanos Natera, Inc. Transaction History
Kynikos Associates LP
- $312 Million
- Q3 2023
A detailed history of Jim Chanos (Kynikos Associates LP) transactions in Natera, Inc. stock. As of the latest transaction made, Kynikos Associates LP holds 47,800 shares of NTRA stock, worth $8.05 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
47,800Holding current value
$8.05 Million% of portfolio
0.31%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NTRA
# of Institutions
528Shares Held
119MCall Options Held
308KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.93 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.14 Billion0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY4.63MShares$780 Million0.05% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.56MShares$768 Million2.91% of portfolio
-
Fred Alger Management, LLC New York, NY4.01MShares$676 Million2.57% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $16.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...